In a filing, Arrowhead Pharmaceuticals Inc revealed its Officer Anzalone Christopher Richard acquired Company’s shares for reported $2.27 million on Mar 04 ’25. In the deal valued at $17.02 per share,133,333 shares were bought.
Then, Anzalone Christopher Richard bought 166,667 shares, generating $3,004,203 in total proceeds.
Before that, OLUKOTUN ADEOYE Y sold 959 shares. Arrowhead Pharmaceuticals Inc shares valued at $20,139 were divested by the Director at a price of $21.00 per share. As a result of the transaction, OLUKOTUN ADEOYE Y now holds 35,781 shares, worth roughly $0.61 million.
Goldman initiated its Arrowhead Pharmaceuticals Inc [ARWR] rating to a Neutral in a research note published on June 05, 2024; the price target was $31. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Citigroup began covering ARWR with “Neutral” recommendation on September 19, 2023. TD Cowen started covering the stock on July 21, 2023. It rated ARWR as “an Outperform”.
Price Performance Review of ARWR
On Tuesday, Arrowhead Pharmaceuticals Inc [NASDAQ:ARWR] saw its stock fall -3.39% to $17.11. Over the last five days, the stock has lost -12.39%. Arrowhead Pharmaceuticals Inc shares have fallen nearly -8.99% since the year began. Nevertheless, the stocks have fallen -46.70% over the past one year. While a 52-week high of $36.72 was reached on 02/07/25, a 52-week low of $17.05 was recorded on 03/04/25. SMA at 50 days reached $19.53, while 200 days put it at $22.27.
Levels Of Support And Resistance For ARWR Stock
The 24-hour chart illustrates a support level at 16.63, which if violated will result in even more drops to 16.14. On the upside, there is a resistance level at 17.54. A further resistance level may holdings at 17.96. The Relative Strength Index (RSI) on the 14-day chart is 34.73, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.40, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.60%. Stochastics %K at 17.01% indicates the stock is a buying.
